Cargando…
Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
Autores principales: | Wang, Jeffrey, Wang, Jacqueline, Lopez, Elyse, Guo, Hui, Zhang, Hui, Liu, Yang, Chen, Zhihong, Huang, Shengjian, Zhou, Shouhao, Leeming, Angela, Zhang, R. J., Jung, Dayoung, Shi, Hannah, Grundman, Hadley, Doakes, Darian, Cui, Kathleen, Jiang, Changying, Ahmed, Makhdum, Nomie, Krystle, Fang, Bingliang, Wang, Michael, Yao, Yixin, Zhang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882812/ https://www.ncbi.nlm.nih.gov/pubmed/31780660 http://dx.doi.org/10.1038/s41408-019-0259-8 |
Ejemplares similares
-
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
por: Huang, Shengjian, et al.
Publicado: (2018) -
Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
por: Ye, Haige, et al.
Publicado: (2018) -
Gene mutations and actionable genetic lesions in mantle cell lymphoma
por: Ahmed, Makhdum, et al.
Publicado: (2016) -
The B cell receptor signaling pathway in mantle cell lymphoma
por: Merolle, Maria I., et al.
Publicado: (2018) -
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
por: Balaji, Swathi, et al.
Publicado: (2018)